HomeIRLAB-A • STO
add
IRLAB Therapeutics AB
Previous close
kr 1.72
Day range
kr 1.64 - kr 1.85
Year range
kr 1.31 - kr 13.88
Market cap
146.13M SEK
Avg Volume
320.05K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 14.72M | -65.61% |
Operating expense | 15.21M | 177.13% |
Net income | -23.49M | -335.44% |
Net profit margin | -159.55 | -1,166.27% |
Earnings per share | — | — |
EBITDA | -20.82M | -7,925.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 81.86M | 22.33% |
Total assets | 138.21M | 1.47% |
Total liabilities | 107.49M | 3.78% |
Total equity | 30.72M | — |
Shares outstanding | 81.88M | — |
Price to book | 4.54 | — |
Return on assets | -35.40% | — |
Return on capital | -75.54% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -23.49M | -335.44% |
Cash from operations | -25.98M | -14.92% |
Cash from investing | — | — |
Cash from financing | -847.00K | 1.51% |
Net change in cash | -28.27M | -20.48% |
Free cash flow | -20.92M | -1.56% |
About
Founded
2013
Website
Employees
31
